FBIO
Price
$1.63
Change
+$0.02 (+1.24%)
Updated
Oct 4 closing price
NTLA
Price
$17.99
Change
+$0.34 (+1.93%)
Updated
Oct 4 closing price
26 days until earnings call
Ad is loading...

FBIO vs NTLA

Header iconFBIO vs NTLA Comparison
Open Charts FBIO vs NTLABanner chart's image
Fortress Biotech
Price$1.63
Change+$0.02 (+1.24%)
Volume$567.31K
CapitalizationN/A
Intellia Therapeutics
Price$17.99
Change+$0.34 (+1.93%)
Volume$1.85M
CapitalizationN/A
View a ticker or compare two or three
FBIO vs NTLA Comparison Chart
Loading...
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FBIO vs. NTLA commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIO is a StrongBuy and NTLA is a Sell.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (FBIO: $1.63 vs. NTLA: $17.99)
Brand notoriety: FBIO and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIO: 111% vs. NTLA: 136%
Market capitalization -- FBIO: $39.91M vs. NTLA: $2.13B
FBIO [@Biotechnology] is valued at $39.91M. NTLA’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIO’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • FBIO’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both FBIO and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIO’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • FBIO’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FBIO is a better buy in the short-term than NTLA.

Price Growth

FBIO (@Biotechnology) experienced а +9.06% price change this week, while NTLA (@Biotechnology) price change was -14.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

FBIO is expected to report earnings on Mar 27, 2024.

NTLA is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.13B) has a higher market cap than FBIO($39.9M). NTLA YTD gains are higher at: -40.997 vs. FBIO (-46.013). FBIO has higher annual earnings (EBITDA): -93.31M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. FBIO (76.2M). FBIO has less debt than NTLA: FBIO (88.4M) vs NTLA (106M). FBIO has higher revenues than NTLA: FBIO (82.6M) vs NTLA (46M).
FBIONTLAFBIO / NTLA
Capitalization39.9M2.13B2%
EBITDA-93.31M-514.18M18%
Gain YTD-46.013-40.997112%
P/E RatioN/AN/A-
Revenue82.6M46M180%
Total Cash76.2M691M11%
Total Debt88.4M106M83%
FUNDAMENTALS RATINGS
FBIO vs NTLA: Fundamental Ratings
FBIO
NTLA
OUTLOOK RATING
1..100
359
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
8587
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (32) in the Biotechnology industry is in the same range as NTLA (42). This means that FBIO’s stock grew similarly to NTLA’s over the last 12 months.

NTLA's Profit vs Risk Rating (96) in the Biotechnology industry is in the same range as FBIO (100). This means that NTLA’s stock grew similarly to FBIO’s over the last 12 months.

NTLA's SMR Rating (96) in the Biotechnology industry is in the same range as FBIO (100). This means that NTLA’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's Price Growth Rating (85) in the Biotechnology industry is in the same range as NTLA (87). This means that FBIO’s stock grew similarly to NTLA’s over the last 12 months.

FBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NTLA (100). This means that FBIO’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIONTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 23 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVIRX35.710.18
+0.51%
Columbia Dividend Income Adv
FUGAX47.440.14
+0.29%
Fidelity Advisor Utilities A
PRDAX11.85N/A
N/A
Principal Diversified Real Asset A
SGARX30.41N/A
N/A
Virtus SGA Global Growth R6
SOIAX9.45-0.03
-0.32%
Spirit of America Real Estate Inc&Gr Ins

FBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with SEER. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then SEER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIO
1D Price
Change %
FBIO100%
+0.93%
SEER - FBIO
40%
Loosely correlated
+3.09%
AXON - FBIO
38%
Loosely correlated
+1.63%
BEAM - FBIO
38%
Loosely correlated
+2.05%
PGEN - FBIO
37%
Loosely correlated
-2.17%
PLRX - FBIO
36%
Loosely correlated
+3.69%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with EDIT. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.93%
EDIT - NTLA
75%
Closely correlated
+5.63%
BEAM - NTLA
75%
Closely correlated
+2.05%
CRSP - NTLA
72%
Closely correlated
+1.05%
VCYT - NTLA
69%
Closely correlated
-0.39%
PRME - NTLA
67%
Closely correlated
+2.93%
More